Characterizing and Addressing Financial Toxicity in AYAs With Cancer
2 other identifiers
interventional
26
1 country
1
Brief Summary
The overall aims of this study are to address two important gaps in care for AYA cancer patients: 1) a financial toxicity measurement tool to assess AYA-specific needs, and 2) an intervention for mitigating financial toxicity in this population. Aim 1 involves adapting the COSTA measure and assessing the psychometric properties of the measure for a racial/ethnically diverse group of AYAs. Aim 2 and 3 involve the development and pilot testing of our novel financial education/ navigation (FE/FN) intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedResults Posted
Study results publicly available
March 16, 2026
CompletedMarch 16, 2026
February 1, 2026
1.3 years
October 3, 2023
January 27, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants Who Completed the Intervention
This is to assess the feasibility of intervention completion. Intervention completion is defined as participants who have demonstrated contact with community partners at any time before the end of 6 months.
Up to 6 months
Number of Eligible Participants Who Received the Intervention
This is to measure interest and the need for help by community partners that can provide patient financial education and navigation.
Up to 6 months
Secondary Outcomes (1)
Comprehensive Score of Financial Toxicity (COST Measure) Score
Baseline, 6 months
Study Arms (1)
Patients Eligible (screened positive)
EXPERIMENTALIndividuals who screen positive will all move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months.
Interventions
The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Eligibility Criteria
You may qualify if:
- AYA patient participants:
- Age 15 - 39 years old
- English or Spanish-speaking
- Diagnosed with cancer that required treatment within past 18 months
- Not currently on hospice care
- Caregiver/financial partner participants:
- Parent or financially-responsible adult of non-adult AYA (\<18 years) OR
- Identified by the AYA as caregiver, parent, or partner who is financially-responsible or a financial partner for AYA
You may not qualify if:
- Unable to complete financial survey questions or contraindicated (as outlined in Protection of Human Subjects)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Patient Advocate Foundationcollaborator
- Columbia Universitylead
- National Center for Advancing Translational Sciences (NCATS)collaborator
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Related Publications (9)
Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381-90. doi: 10.1634/theoncologist.2012-0279. Epub 2013 Feb 26.
PMID: 23442307BACKGROUNDAltice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial Hardships Experienced by Cancer Survivors: A Systematic Review. J Natl Cancer Inst. 2016 Oct 20;109(2):djw205. doi: 10.1093/jnci/djw205. Print 2017 Feb.
PMID: 27754926BACKGROUNDYabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X, Virgo KS, McNeel TS, Chawla N, Blanch-Hartigan D, Kent EE, Li C, Rodriguez JL, de Moor JS, Zheng Z, Jemal A, Ekwueme DU. Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors. J Clin Oncol. 2016 Jan 20;34(3):259-67. doi: 10.1200/JCO.2015.62.0468. Epub 2015 Dec 7.
PMID: 26644532BACKGROUNDParsons HM, Harlan LC, Lynch CF, Hamilton AS, Wu XC, Kato I, Schwartz SM, Smith AW, Keel G, Keegan TH. Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol. 2012 Jul 1;30(19):2393-400. doi: 10.1200/JCO.2011.39.6333. Epub 2012 May 21.
PMID: 22614977BACKGROUNDNipp RD, Kirchhoff AC, Fair D, Rabin J, Hyland KA, Kuhlthau K, Perez GK, Robison LL, Armstrong GT, Nathan PC, Oeffinger KC, Leisenring WM, Park ER. Financial Burden in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2017 Oct 20;35(30):3474-3481. doi: 10.1200/JCO.2016.71.7066. Epub 2017 Aug 17.
PMID: 28817372BACKGROUNDde Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, Hlubocky FJ, Nicholas LH, O'Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella D. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017 Feb 1;123(3):476-484. doi: 10.1002/cncr.30369. Epub 2016 Oct 7.
PMID: 27716900BACKGROUNDDanhauer SC, Canzona M, Tucker-Seeley RD, Reeve BB, Nightingale CL, Howard DS, Puccinelli-Ortega N, Little-Greene D, Salsman JM. Stakeholder-informed conceptual framework for financial burden among adolescents and young adults with cancer. Psychooncology. 2022 Apr;31(4):597-605. doi: 10.1002/pon.5843. Epub 2021 Nov 5.
PMID: 34699110BACKGROUNDBeauchemin MP, Elkin EB, Wright JD, Kukafka R, Hershman DL, Kahn J. Incorporating systematic financial screening into the electronic health record. Journal of Clinical Oncology. 2021;39(28_suppl):184-184.
BACKGROUNDKhurana RK, Valera K, Raghunathan R, Gallagher KD, Angove RS, Bradshaw E, Patton J, Alvarado S, Crespo S, Judon K, DiCola K, Steinberg DM, Wang S, Hershman DL, Beauchemin MP. Pilot feasibility of a financial and health-related social needs navigation intervention (AYA-NAV) for adolescents and young adults with Cancer: Study protocol for a prospective, single-arm study. Contemp Clin Trials Commun. 2025 Jul 16;47:101523. doi: 10.1016/j.conctc.2025.101523. eCollection 2025 Oct.
PMID: 40726516DERIVED
MeSH Terms
Conditions
Results Point of Contact
- Title
- Melissa Beauchemin
- Organization
- Columbia University School Of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa Beauchemin
Columbia University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Nursing
Study Record Dates
First Submitted
October 3, 2023
First Posted
October 10, 2023
Study Start
November 15, 2023
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
March 16, 2026
Results First Posted
March 16, 2026
Record last verified: 2026-02